Edition:
United States

BioLine RX Ltd (BLRX.OQ)

BLRX.OQ on NASDAQ Stock Exchange Capital Market

0.92USD
25 May 2018
Change (% chg)

$0.02 (+2.21%)
Prev Close
$0.90
Open
$0.94
Day's High
$0.94
Day's Low
$0.90
Volume
43,090
Avg. Vol
43,019
52-wk High
$1.34
52-wk Low
$0.78

Revenue & Earnings Per Share

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 238.69 33.30
P/E High - Last 5 Yrs. -- 290.32 47.06
P/E Low - Last 5 Yrs. -- 99.28 24.86
Beta -- 0.74 0.78
Price to Sales (TTM) -- 247.63 8.09
Price to Book (MRQ) -- 24.09 4.47
Price to Tangible Book (MRQ) -- 27.23 5.99
Price to Cash Flow (TTM) -- 136.35 22.28
% Owned Institutions -- 10.88 2.37

Dividends

  Company industry sector
Dividend Yield -- 0.30 1.62
Dividend Yield - 5 Year Avg -- 0.20 0.77
Dividend 5 Year Growth Rate -- 2.28 3.80
Payout Ratio(TTM) -- 45.83 17.45

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 26.61 5.09
Sales (TTM) vs TTM 1 Yr. Ago -- 147.97 12.55
Sales - 5 Yr. Growth Rate -- 30.86 7.98
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -91.02 34.61
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 48.48 8.28
Capital Spending - 5 Yr. Growth Rate -- 40.00 8.10

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.63 2.56
Current Ratio (MRQ) -- 6.51 3.65
LT Debt to Equity (MRQ) -- 22.25 12.74
Total Debt to Equity (MRQ) -- 25.70 16.30
Interest Coverage (TTM) -- -173.02 35.37

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.80
Gross Margin - 5 Yr. Avg. -- 54.86 52.64
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -152.51 15.90
Operating Margin (TTM) -- -867.63 0.55
Operating Margin - 5 Yr. Avg. -- -165.00 11.23
Pre-Tax Margin (TTM) -- -756.28 2.56
Pre-Tax Margin - 5 Yr. Avg. -- -169.57 11.46
Net Profit Margin (TTM) -- -748.18 -0.89
Net Profit Margin - 5 Yr. Avg. -- -168.96 7.75
Effective Tax Rate (TTM) -- 14.67 31.22
Effective Tax Rate - 5 Yr. Avg. -- 19.46 24.28

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 22,075,134 745,954,659
Net Income/Employee (TTM) -- -795,133 86,895,337
Receivable Turnover (TTM) -- 17.26 5.95
Inventory Turnover (TTM) -- 2.45 3.58
Asset Turnover (TTM) -- 0.42 0.87

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -- -5.32 10.30
Return on Assets - 5 Yr. Avg. -- -0.30 11.20
Return on Investment (TTM) -- -7.54 13.04
Return on Investment - 5 Yr. Avg. -- 2.97 14.50
Return on Equity (TTM) -- -10.33 14.90
Return on Equity - 5 Yr. Avg. -- -2.83 15.82
Note: Units in Millions of US Dollars

Performance for BioLine RX Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.